News

Insolvent German hospital group Paracelsus-Kliniken finds buyer

Swiss family-owned investment group Porterhouse is to acquire insolvent German hospital and rehabilitation group Paracelsus-Kliniken after a committee of creditors approved the sale. [+]

Insight & Interviews

Interview: Ruben Bhagobati, AMP Capital

Australia-based global investment group AMP Capital bought The Regard Group, a UK-based specialist care business, at the end of last year. Healthcare Europa catches up with Ruben Bhagobati, who heads up the company's infrastructure investment arm in Europe, to find out why he thinks the European specialist care market is the one to watch. [+]

Reports

Real solutions for retention and recruitment

Recruitment, retention and training are now the primary challenges for the healthcare services industry. The obvious solution to keeping staff - paying more – is no longer working. Private operators around the world are now fishing in a global market that's short of 15m healthcare workers. So what practical solutions are operators putting into force and what really works? We talk to 25 operators from across the world. [+]
See All Healthcare Europa >

News

The problems with investing in MENA

The biggest problem with investing in healthcare in MENA isn’t returning capital – it’s raising it in the first place. But it's not the only problem. Dr Helmut Scheuhsler, chairman and managing partner for TVM Capital in Dubai and Munich, shared his thoughts about at HBI 2018. [+]

Insight & Interviews

Interview: Ricardo Soares, CEO, Brasil Senior Living

Brasil Senior Living (BSL) is establishing a network of elderly and assisted living homes in Brazil - and currently has little by way of organised opposition there. Healthcare Nova talks to CEO and co-founder Ricardo Soares about his plans for the future, why he'd welcome a rival, and what he makes of Orpea's plans to enter the market. [+]

Reports

Traditional Chinese medicine flourishes at home – but could prove a tough export

The Chinese government is promoting traditional Chinese medicine globally, and is authorising payments from insurers for certain treatments. Despite that support, it still faces an uphill battle abroad. Healthcare Nova speaks to a market source. [+]
See All Healthcare Nova >